Name: GU Sai 古赛
Areas of Research:
1. Physical and mental diseases of the digestive system
Such diseases in the digestive system have 2 main categories: organic diseases of the digestive system with mental disorders, and digestive functional disorders associated with mental disorders. My research mainly focuses on the latter, especially Functional Dyspepsia with anxiety, depression or other mental disorders. Such diseases feature high incidence rate, large social impact. Because the pathogenesis is still unclear, the clinical treatment is difficult and the efficacy unsatisfactory. Therefore it is desired to study the drug clinical efficacy and mechanism, including my ongoing research on the diseases’ neurotransmission, nerve conduction, and nerve immunization.
2. Fatty liver disease
Both alcoholic and non-alcoholic fatty liver diseases feature a high incidence rate in China. It is the primary cause of cirrhosis, liver cancer, and other end-stage liver diseases, therefore has a considerable negative social impact. My current research in this area includes the study of the progressive mechanism from alcohol to liver diseases, the insulin resistance and the meditating role of adipocytokine in non-alcoholic liver dieseases, as well as the mechanism and effect of the Chinese medicine in reversing fatty liver diseases.
3. Helicobacter pylori
Over 50% of the Chinese population are infected by the helicobacter pylori. It is highly related to the incidence of atrophic gastritis and gastric cancer. Its radical treatment has extensive drug resistance (XDR). My research in this area includes local Helicobacter pylori infection and its drug resistance mechanism.
Chief Physician of Gastroenterology
Deputy Director, First Affiliated Hospital of Chongqing Medical University, Jinshan Hospital Medicine
Deputy Director, Chongqing Medical University "Experimental Teaching Center of Clinical Skills"
Deputy Team Lead, Chinese Medical Association Chongqing pylori Collaboration Team
Bachelor of Clinical Medicine, Chongqing Medical University – 1990
Master of Gastroenterology, Chongqing Medical University – 1999
Medical Doctor (M.D.) of Gastroenterology, Chongqing Medical University – 2007
Resident Physician, Department of Gastroenterology, First Affiliated Hospital of Chongqing Medical University – Jul. 1990 to Apr. 1996
Attending Physician, Department of Gastroenterology, First Affiliated Hospital of Chongqing Medical University – Apr. 1996 to Nov. 2003
Deputy Chief Physician, Department of Gastroenterology, First Affiliated Hospital of Chongqing Medical University – Nov. 2003 to Apr. 2013
Chief Physician, Department of Gastroenterology, First Affiliated Hospital of Chongqing Medical University – Apr. 2013 to Present
1. Xia Hong, Sai Gu. Risk factors for refractory irritable bowel syndromediarrhea. The world Chinese people digest magazine .2014,22(7):1022-1026.
2. NIe Ying, Sai Gu..Efficacy observation of anti-anxiety and depression drug combined with PPI in the treatment of refractory reflux esophagitis. Chinese journal of pharmacy. .2014，25（10）；910-912.
3. Guo fan li, Sai Gu. The Research of Lycium Barbarum Polysccharide in the Prevention and Treatment of Non-alcoholic Fatty Liver Disease. Journal of Chongqing Medical University.2015, 40（11）:1481-1485.
The effect and mechanism of the liver capsules on treating alcoholic liver fibrosis (2008) Chongqing Municipal Health Bureau research project, System evaluation and prevention of the non-invasive assessment of non-alcoholic simple fatty liver and steatohepatitis (2009) Chongqing Municipal Health Bureau research project, Prevention and treatment of non-alcoholic fatty liver by regulating the adiponectin using LBP (2011) Chongqing Municipal Health Bureau research project, Research and experiment of the bi-lingual online course instruction system in diagnostics (2011) Chongqing Municipal Education Commission research project.
Recruitment and Category:
Area of study: gastroenterology
Level of study: pursuing the master degree